2-(2,3-二氢-1,5-二甲基-3-氧代-2-苯基-1H-吡唑-4-基)-2,3-二氢-1,3-二氧代-1H-异吲哚-5-甲酸
2-(2,3-二氢-1,5-二甲基-3-氧代-2-苯基-1H-吡唑-4-基)-2,3-二氢-1,3-二氧代-1H-异吲哚-5-甲酸结构式
|
常用名 | 2-(2,3-二氢-1,5-二甲基-3-氧代-2-苯基-1H-吡唑-4-基)-2,3-二氢-1,3-二氧代-1H-异吲哚-5-甲酸 | 英文名 | BV 02 |
|---|---|---|---|---|
| CAS号 | 292870-53-2 | 分子量 | 377.350 | |
| 密度 | 1.5±0.1 g/cm3 | 沸点 | 593.8±60.0 °C at 760 mmHg | |
| 分子式 | C20H15N3O5 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 312.9±32.9 °C | |
| 符号 |
GHS09 |
信号词 | Warning |
|
Designing anti-influenza aptamers: novel quantitative structure activity relationship approach gives insights into aptamer-virus interaction.
PLoS ONE 9(5) , e97696, (2014) This study describes the development of aptamers as a therapy against influenza virus infection. Aptamers are oligonucleotides (like ssDNA or RNA) that are capable of binding to a variety of molecular targets with high affinity and specificity. We have studie... |
期刊文献综述：
更多...